Encapsulated zinc salt increases the diffusion of protein through PLG films

International Journal of Pharmaceutics

Volumn 370, Issue 1-2, 2009, Pages 47-53

  Fredenberg, Susanne ^a   Reslow, Mats ^b   Axelsson, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Controlled release; Degradation; Diffusion; Poly(d,l lactide co glycolide); Pore formation; Zinc salt

Indexed keywords

BUFFER; LYSOZYME; POLYGLACTIN; ZINC ACETATE; ZINC DERIVATIVE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFUSION; DRUG DELIVERY SYSTEM; ENCAPSULATION; FILM; IMAGE ANALYSIS; POROSITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; PROTEIN TRANSPORT; SCANNING ELECTRON MICROSCOPY; THICKNESS;

BUFFERS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MURAMIDASE; POLYGLYCOLIC ACID; POLYMERS; POROSITY; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; ZINC ACETATE;

EID: 61349181810     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.11.017     Document Type: Article

References (35)

1. Batycky R.P., Hanes J., Langer R., and Edwards D.A. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J. Pharm. Sci. 86 (1997) 1464-1477
2. Berkland C., Pollauf E., Raman C., Silverman R., Kim K., and Pack D.W. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism. J. Pharm. Sci. 96 (2007) 1176-1191
3. Bilati U., Allemann E., and Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur. J. Pharm. Biopharm. 59 (2005) 375-388
4. Borgquist P., Nevsten P., Nilsson B., Wallenberg R., and Axelsson A. Simulation of the release from multiparticulate system-single pellet and dose release. J. Controlled Release 97 (2004) 453-465
5. Carino G.P., Jacob J.S., and Mathiowitz E. Nanosphere based oral insulin delivery. J. Controlled Release 65 (2000) 261-269
6. Cleland J.L., Johnson O.L., Putney S., and Jones A.J.S. Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development. Adv. Drug Deliv. Rev. 28 (1997) 71-84
7. Duvvuri S., Janoria K.G., and Mitra A.K. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. J. Controlled Release 108 (2005) 282-293
8. Fredenberg, S., 2004. PLG films in controlled release pharmaceuticals-diffusion and degradation. Licentiate Thesis. Lund University, Sweden.
9. Fredenberg S., Reslow M., and Axelsson A. Measurement of protein diffusion through poly(d,l-lactide-co-glycolide). Pharm. Dev. Technol. 10 (2004) 299-307
10. Fredenberg S., Reslow M., and Axelsson A. Effect of divalent cations on pore formation and degradation of poly(d,l-lactide-co-glycolide). Pharm. Dev. Technol. 12 (2007) 563-572
11. Houchin M.L., Neuenswander S.A., and Topp E.M. Effect of excipients on PLGA film degradation and the stability of an incorporated peptide. J. Controlled Release 117 (2007) 413-420
12. Ishihara T., Izumo N., Higaki M., Shimada E., Hagi T., Mine L., Ogawa Y., and Mizushima Y. Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile. J. Controlled Release 105 (2005) 68-76
13. Johnson O.L., Cleland J.L., Jung Lee H., Charnis M., Duenas E., Jaworowicz W., Shepard D., Shahzamani A., Jones A.J.S., and Putney S.D. A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. 2 (1996) 795-799
14. Johnson O.L., Jaworowicz W., Cleland J.L., Bailey L., Charnis M., Duenas E., Wu C., Shepard D., Magil S., Last T., Jones A.J.S., and Putney S.D. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 14 (1997) 730-735
15. Kang J., and Schwendeman S.P. Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins. Mol. Pharm. 4 (2007) 104-118
16. Kim H.K., and Park T.G. Comparative study on sustained release of human growth hormone from semi-crystalline poly(l-lactic acid) and amorphous poly(d,l-lactic-co-glycolic acid) microspheres: morphological effect on protein release. J. Controlled Release 98 (2004) 115-125
17. Lagarce F., Renaud P., Faisant N., Nicolas G., Cailleux A., Richard J., Menei P., and Benoit J.-P. Baclofen-loaded microspheres: preparation and efficacy testing in a new rabbit model. Eur. J. Pharm. Biopharm. 59 (2005) 449-459
18. Lam X.M., Duenas E.T., Daugherty A.L., Levin N., and Cleland J.L. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J. Controlled Release 67 (2000) 281-292
19. Li L., and Schwendeman S.P. Mapping neutral microclimate pH in PLGA microspheres. J. Controlled Release 101 (2005) 163-173
20. Liu F.-I., Kuo J.H., Sung K.C., and Hu O.Y.P. Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies. Int. J. Pharm. 257 (2003) 23-31
21. Liu W.H., Song J.L., Liu K., Chu D.F., and Li Y.X. Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease. J. Controlled Release 107 (2005) 417-427
22. Mattisson, C., 1999. Diffusion studies in gels using holographic interferometry. Ph.D. Thesis. Lund University, Sweden.
23. Park T.G. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials 16 (1995) 1123-1130
24. Pratt L., Chu C., Auer J., Kim J., Zollweg J.A., and Chu C.C. The effect of ionic electrolytes on hydrolytic degradation of biodegradable polymer: mechanical and thermodynamic properties and molecular modeling. J. Polym. Sci., Part A: Polym. Chem. 31 (1993) 1759-1769
25. Reslow M., Jönsson M., and Laakso T. Sustained-release of human growth hormone from PLG-coated starch microspheres. Drug Deliv. Syst. Sci. 2 (2002) 103-109
26. Ross Colvin J. The size and shape of lysozyme. Can. J. Chem. 30 (1952) 831-834
27. Shenderova A., Burke T.G., and Schwendeman S.P. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm. Res. 16 (1999) 241-248
28. Takada S., Yamagata Y., Misaki M., Taira K., and Kurokawa T. Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. J. Controlled Release 88 (2003) 229-242
29. Takenaga M., Yamaguchi Y., Kitagawa A., Ogawa Y., Kawai S., Mizushima Y., and Igarashi R. Optimum formulation for sustained-release insulin. Int. J. Pharm. 271 (2004) 85-94
30. Tracy M.A., Ward K.L., Firouzabadian L., Wang Y., Dong N., Qian R., and Zhang Y. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 20 (1999) 1057-1062
31. Walsh G. Pharmaceutical biotechnology products approved within the European Union. Eur. J. Pharm. Biopharm. 55 (2003) 3-10
32. Webber W.L., Lago F., Thanos C., and Mathowitz E. Characterization of soluble, salt-loaded, degradable PLGA films and their release of tetracycline. J. Biomed. Mater. Res. 41 (1998) 18-29
33. Westrin, B.A., 1991. Diffusion measurement in gels: a methodological study. Ph.D. Thesis. Lund University, Sweden.
34. Zhang Y., Zale S., Sawer L., and Bernstein H. Effects of metal salts on poly(d,l-lactide-co-glycolide) polymer hydrolysis. J. Biomed. Mater. Res. 34 (1997) 531-538
35. Zhu G., and Schwendeman S.P. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives. Pharm. Res. 17 (2000) 351-357